Given that real-world data for injectables has reported up to 64.8% discontinuation within 1-year in non-diabetic individuals (JAMA Network Open), my question will be how oral GLP-1s compare
monitoring renal function is advisable in at-risk patients
It slows digestion, reduces appetite by communicating with the brains appetite control centre, and helps the pancreas release insulin to regulate blood sugar
STEP trials showed approximately 40% of weight loss was lean mass
And here's the thing a lot of people miss: liquid meals are one of the easiest formats for GLP-1 users, especially on days when solid food feels like too much
In 2015, 32 white rabbits were divided into four groups of eight, and each group was given a placebo, AOD 9604, hyaluronic acid, or a combination of AOD 9604 and hyaluronic acid for 4 to 7 weeks